Filing Context and Reporting Period
Important identity discrepancy: The request identifies USA Rare Earth, Inc., but the supplied Form 10-Q is for Inflection Point Acquisition Corp. II, a Cayman Islands special purpose acquisition company. The filing covers the quarter ended June 30, 2023 and the period from March 6, 2023 inception through June 30, 2023. The financial statements are unaudited.
The company had not selected a business combination target and had not commenced operating activities. It expects no operating revenue until after a business combination.
Financial Condition and Results
| Metric | Three months ended June 30, 2023 | Inception through June 30, 2023 |
|---|---|---|
| Operating revenue | None | None |
| Formation and operating costs | $228,650 | $234,853 |
| Interest income from Trust Account | $1,059,469 | $1,059,469 |
| Net income | $830,819 | $824,616 |
| Basic and diluted EPS attributable to redeemable shares | $1.18 | $1.70 |
| Basic and diluted EPS attributable to non-redeemable shares | $(1.47) | $(1.68) |
- Total assets were $253.4 million, including $252.3 million of marketable securities held in the Trust Account and $545,738 of cash.
- Current liabilities were $150,039. Total liabilities were $13.25 million, including $13.1 million of deferred underwriting fees payable upon completion of a business combination.
- Class A shares subject to possible redemption were recorded as temporary equity at $252.3 million, or $10.09 per share.
- Shareholders’ deficit was $12.17 million.
- Net cash used in operating activities from inception was $602,933. Net cash used in investing activities was $251.25 million, reflecting funding of the Trust Account. Net cash provided by financing activities was $252.4 million.
- The company reported working capital of $928,270 and stated that it had no long-term debt, capital leases, operating leases, or other off-balance-sheet arrangements.
Material Changes and Capitalization
- On May 30, 2023, the company completed its initial public offering of 25 million units at $10.00 per unit, generating gross proceeds of $250 million. The offering included the underwriters’ partial exercise of their over-allotment option.
- The company simultaneously sold 7.65 million private placement warrants for $7.65 million.
- Of the combined proceeds, $251.25 million was deposited into the Trust Account. Transaction costs totaled $18.36 million, including $4.4 million of cash underwriting discounts, $13.1 million of deferred underwriting fees, and $861,877 of other offering costs.
- As of June 30, 2023, 25 million Class A shares were subject to possible redemption, 6.25 million Class B founder shares were outstanding, and 20.15 million warrants were outstanding.
- There is no meaningful prior comparable operating period because the company was formed on March 6, 2023.
Outlook, Risks, and Unusual Items
- The company has an 18-month completion window from the IPO closing, unless an earlier liquidation date is approved. If it does not complete a business combination within that period, it expects to redeem the public shares using Trust Account funds, subject to applicable law and creditor claims.
- Management stated that the company’s cash outside the Trust Account is expected to fund planned activities, including target identification, due diligence, transaction expenses, insurance, and monthly payments of $27,083.33 to The Venture Collective LLC for executive and staff services.
- Management identified substantial doubt about the company’s ability to continue as a going concern because it expects to incur significant costs and may need additional financing. The Sponsor and related parties may provide working-capital loans, but are not obligated to do so.
- The company had no identified business combination target and provided no operating or financial guidance.
- The deferred underwriting fee, redemption rights, potential shareholder redemptions, and the requirement to meet business-combination conditions could materially affect available transaction capital.
- The Sponsor agreed to indemnify the company in certain circumstances if third-party claims reduce Trust Account funds below specified levels, but the company has not verified that the Sponsor has sufficient assets to satisfy the obligation.
- The company disclosed general uncertainty related to the COVID-19 pandemic and the Russia-Ukraine conflict but stated that their specific effects were not determinable.
- Management concluded that disclosure controls and procedures were effective at a reasonable assurance level, with no material changes to internal control over financial reporting during the quarter.
Investor Verification Items
- Verify the issuer identity and ticker because the supplied filing is for Inflection Point Acquisition Corp. II, not USA Rare Earth, Inc.
- Confirm the applicable business-combination deadline, any subsequent target announcement, and whether the completion window has been amended.
- Review Trust Account balances, accrued interest, deferred underwriting fees, taxes, and any public-share redemptions.
- Assess the company’s ability to fund operations outside the Trust Account and whether Sponsor or related-party financing has been obtained.
- Evaluate dilution from 6.25 million founder shares and 20.15 million outstanding warrants, including the $11.50 warrant exercise price.
- Review related-party service payments and any subsequent changes to the Sponsor’s indemnification or working-capital obligations.